Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2017
18th World Conference on Lung Cancer
Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan
Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Download PDF of the Conference Program: Click Here.
Presentations will be available 24 hours after their live presentation time
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
-
+
P1.07 - Immunology and Immunotherapy
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
- Presentations: 48
- Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P1.07-010 - Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab
09:30 - 09:30 | Presenter: Junko Tanizaki
- Abstract
Loading...
-
+
OA 05 - Next Generation TKI
- Type: Oral
- Track: Advanced NSCLC
- Presentations: 9
- Moderators:James Chih-Hsin Yang
- Coordinates: 10/16/2017, 15:45 - 17:30, Room 301 + 302
-
+
OA 05.01 - First-Line Dacomitinib versus Gefitinib in Advanced Non-Small-Cell Lung Cancer with EGFR Mutation Subgroups
15:45 - 15:55 | Presenter: Yi-Long Wu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA 05.03 - Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients with EGFR Activating and T790M Mutations
16:05 - 16:15 | Presenter: Keunchil Park
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA 05.08 - Final Result of Phase I/II Study (AF-001JP) of Alectinib, a Selective CNS-Active ALK Inhibitor, in ALK+ NSCLC Patients (Pts)
17:00 - 17:10 | Presenter: Makoto Nishio
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.03 - Chemotherapy/Targeted Therapy
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
- Presentations: 59
- Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P2.03-008 - Phase I/II Study of Intermitted Erlotinib in Combination with Docetaxel in Patients with Recurrent NSCLC with Wild-Type EGFR: WJOG 4708L
09:30 - 09:30 | Presenter: Tatsuo Kimura
- Abstract
Loading... -
+
P2.03-045 - Updated Results of Phase II, Liquid Biopsy Study in EGFR Mutated NSCLC Patients Treated with Afatinib (WJOG 8114LTR)
09:30 - 09:30 | Presenter: Hidetoshi Hayashi
- Abstract
Loading... -
+
P2.03-058a - T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive NSCLC
09:30 - 09:30 | Presenter: Takeshi Yoshida
- Abstract
No abstract available for this presentation
-
+
P2.07 - Immunology and Immunotherapy
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
- Presentations: 65
- Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P2.07-021 - A Checkpoint Molecule B7-H3 as a Novel Immune Therapy Target for Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Kimio Yonesaka
- Abstract
Loading...
-
+
P2.15 - SCLC/Neuroendocrine Tumors
- Type: Poster Session with Presenters Present
- Track: SCLC/Neuroendocrine Tumors
- Presentations: 17
- Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P2.15-004 - Underrepresentation of Elderly Patients with ED-SCLC as Clinical Trial Candidates (JCOG1201/TORG1528)
09:30 - 09:30 | Presenter: Yuki Misumi
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
- Presentations: 97
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.01-012 - Symptom Impact of First-Line Dacomitinib versus Gefitinib in EGFR-Positive NSCLC: Results from a Randomized Phase 3 Study
09:30 - 09:30 | Author(s): M.R. Migliorino
- Abstract
Loading... -
+
P3.01-071 - Randomized Phase 1b/3 Study of Erlotinib + Ramucirumab in Untreated EGFR Mutation-Positive Stage IV NSCLC: Phase 1b Outcomes
09:30 - 09:30 | Presenter: Kazuhiko Nakagawa
- Abstract
Loading... -
+
P3.01-072 - Dacomitinib Versus Gefitinib for First-Line Treatment of Advanced EGFR+ NSCLC in Japanese Patients (ARCHER 1050)
09:30 - 09:30 | Presenter: Kazuhiko Nakagawa
- Abstract
Loading...
-
+
MA 19 - Mesothelioma: Bench to Bedside
- Type: Mini Oral
- Track: Mesothelioma
- Presentations: 12
- Moderators:Dean A Fennell
- Coordinates: 10/18/2017, 11:00 - 12:30, Room 315
-
+
MA 19.01 - A Phase II Study of Nivolumab: A Multicenter, Open-Label, Single Arm Study in Malignant Pleural Mesothelioma (MERIT)
11:00 - 11:05 | Presenter: Yasushi Goto
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PC 03 - 3-1 What is the Optimal Sequence of ALK-TKI for ALK-Positive Lung Cancer? (Alectinib First or Crizotinib First)
- Type: Pros & Cons
- Track: Chemotherapy/Targeted Therapy
- Presentations: 2
- Moderators:Rafal Dziadziuszko
- Coordinates: 10/18/2017, 11:00 - 11:40, Room 303 + 304
-
+
PC 03.02 - Alectinib First
11:20 - 11:40 | Presenter: Kazuhiko Nakagawa
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
